Novotech Releases Report on Global Bladder Cancer Clinical Trials, Offering Insights for Oncology Advancement
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has released an in-depth report, Bladder Cancer – Global Clinical Trial Landscape 2024, offering key insights for stakeholders across the oncology and clinical research sectors.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241120379204/en/
Bladder cancer remains a significant health challenge worldwide, with over 614,000 new cases and 220,600 deaths recorded in 2022. Novotech’s latest report provides a detailed examination of the evolving landscape in bladder cancer research, with a focus on clinical trial trends, emerging therapeutic strategies, and regional variations in patient outcomes.
Key Highlights from the Report:
- Bladder Cancer Statistics: A thorough analysis of incidence and survival data, highlighting that Europe and Asia account for the majority of global cases.
- Clinical Trial Landscape: An overview of over 1,500 bladder cancer clinical trials initiated since 2019, with North America, Asia-Pacific, and Europe leading in trial volume.
- Advancements in Treatment: Exploration of innovative therapies, including immunotherapy, targeted treatments, and combination therapies, which are opening new avenues in bladder cancer care.
- Future Projections: Bladder cancer cases are projected to exceed 1.2 million annually by 2050, underscoring the urgent need for advanced treatment options and accessible healthcare solutions.
This report explores valuable information for biotech professionals, oncologists, researchers and scientists. By examining trial density, recruitment efficiencies, and regional disparities in treatment outcomes, the report provides actionable insights for those aiming to enhance the efficiency and effectiveness of bladder cancer trials.
To access the full report and gain a deeper understanding of the trends shaping bladder cancer research, download the report here.
About NovotechNovotech-CRO.com
Founded in 1997, Novotech is a global full-service clinical Contract Research Organization (CRO) focused on partnering with biotech companies to accelerate the development of advanced and novel therapeutics at every phase.
Recognized for its industry-leading contributions, Novotech has received numerous prestigious awards, including the Frost & Sullivan 2024 Global Biotech CRO of the year award, Clinical Trials Arena Excellence Awards 2024, 2024 Employer of Choice, 2024 Great Place to Work in the US, 2024 Brandon Hall Gold Award, CRO Leadership Award 2023, the Asia Pacific Cell & Gene Therapy Clinical Trials Excellence 2023, the Asia-Pacific Contract Research Organization Company of the Year Award since 2006.
The Company offers a comprehensive suite of services including laboratories, Phase I facilities, drug development consulting, regulatory expertise, and has experience with over 5,000 clinical projects, including Phase I to Phase IV clinical trials and bioequivalence studies. With a presence in 34 office locations and a dedicated team of 3,000+ professionals worldwide, Novotech is a trusted end-to-end strategic partner of choice.
For more information or to speak to an expert team member visit www.Novotech-CRO.com
View source version on businesswire.com: https://www.businesswire.com/news/home/20241120379204/en/
Contacts
Media
Toyna Chin
mediacontact@novotech-cro.com
USA: +1 415 364 8135
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Under the Patronage of HRH the Crown Prince, Saudi Arabia is readying to Host Landmark World Investment Conference (WIC) 2024 in Riyadh.24.11.2024 17:06:00 EET | Press release
Under the patronage of His Royal Highness Crown Prince and Prime Minister Mohammed bin Salman bin AbdulAziz Al Saud, the World Association of Investment Promotion Agencies (WAIPA) and Invest Saudi are organizing the 28th annual World Investment Conference (WIC) from November 25 to 27, in Riyadh. This prestigious event will gather global leaders in investment, government, and international organizations to address the theme, ‘Harnessing Digital Transformation and Sustainable Growth: Scaling Investment Opportunities’. His Excellency Khalid Al-Falih, Minister of Investment of Saudi Arabia, commented: “Under the wise leadership of the Custodian of the Two Holy Mosques; King Salaman bin AbdulAziz Al Saud and His Royal Highness Crown Prince and Prime Minister, Mohammed bin Salman bin AbdulAziz Al Saud, the Kingdom, driven by its ambitious “Vision 2030”, has become a premier world investment destination and is experiencing unprecedented growth in overall investment amounts and diversity.” “Th
Record Asset Management GmbH and OWI Group PLC Launch Deep Tier Supply Chain Finance (DTSCF) Strategy22.11.2024 19:52:00 EET | Press release
Record Asset Management GmbH (“RAM” or “the Company”), part of Record Financial Group (Record plc) to launch with OWI Group PLC, a global institutional sharia compliant investment platform, the world’s first Deep Tier Supply Chain Sharia-compliant fund with a target of USD 1 billion. The new fund will be managed by RAM with support from Khalij Group (“Khalij”), an award winning Islamic investment and advisory boutique, authorised and regulated by the FCA. Khalij is headquartered in the UK with a global clientele and footprint. This innovative fund will draw upon a mix of international investors including family offices and development financial institutions and will be made available for distribution in several European, Asian, and Middle East countries. The fund’s innovative approach will help to bridge the trade finance gap by directing much-needed liquidity to underserved borrowers with high-quality credit and attractive return profiles. The strategy aligns Sharia principles with th
Puma Reimagines Modern Retail With Las Vegas Flagship Store Unveiling22.11.2024 16:28:00 EET | Press release
PUMA has officially opened the doors to its second North American flagship store in Las Vegas at the BLVD Las Vegas.The 25,000-square-foot retail space, which spans an impressive three stories, redefines what it means to be a brick-and-mortar location in today's rapidly evolving digital world. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241122707386/en/ Ribbon cutting at new PUMA Las Vegas Flagship Store Opening (Photo: Business Wire) “I am thrilled that we are opening a state-of-the-art flagship store in Las Vegas as part of our brand elevation strategy. Located along the iconic Las Vegas Strip, this flagship allows us to expand PUMA’s presence in North America to connect with U.S consumers and international visitors alike,” said Arne Freundt, Chief Executive Officer of PUMA. “I believe that our new Las Vegas Flagship is essential for conveying the true character of our PUMA Brand and for creating an immersive, interacti
Seoul Semiconductor: Europe Enhances Eye Protection for Final Inspection Inspectors22.11.2024 16:00:00 EET | Press release
Top-tier European automakers have recognized the need for lighting that replicates the natural light spectrum to protect the eyesight of inspectors at final shipment inspection lines and easily detect fine paint defects on vehicles. In response, Seoul Semiconductor has adopted its SunLike lighting technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241122553628/en/ SunLike Precise Surface Inspection Lights for Automotive (Photo: Broll Systemtechnik) Inspections are now being conducted at the shipment lines of mass production factories, as announced on the 22nd by Seoul Semiconductor Co., Ltd. (KOSDAQ: 046890) and the German specialty lighting company Broll Systemtechnik. A Broll representative stated, "The SunLike technology, which replicates natural light without color distortion, has enhanced the ability to detect exterior defects. In particular, thanks to the natural light technology, it has helped reduce serious v
Novotech Publishes Comprehensive Report on the Global Vaccine Clinical Trials Landscape22.11.2024 15:05:00 EET | Press release
Novotech, the global full-service clinical Contract Research Organization (CRO) that partners with biotech companies to accelerate the development of advanced and novel therapeutics at every phase, has published an in-depth whitepaper titled "Vaccines – Global Clinical Trial Landscape (2024)." This report provides a comprehensive analysis of the evolving vaccine development landscape, offering strategic insights for biotech and pharma stakeholders. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241122751296/en/ The whitepaper examines trends in prophylactic and therapeutic vaccine trials, highlighting advancements and emerging challenges. Key topics covered include the expansion of mRNA platforms, innovative delivery methods, and efforts toward equitable vaccine access by organizations such as WHO and Gavi. Highlights: Emerging Trends: A shift towards adaptive trial designs, personalized vaccine trials, and novel delivery me
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom